Foresee Pharmaceuticals announces reaching a significant milestone, of complete enrollment of its Phase 3 Casppian trial for patients with Central Precocious Puberty (CPP)
Oil futures and US futures drop after Trump warns 'everyone' to evacuate Tehran
MUSC Health doubles down on patient access transformation with Notable
Switzerland sentences former Pictet employee for money laundering